Markus Raderer

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 209 publications

B7-H3 (CD276) as a candidate therapeutic target in medullary thyroid cancer.

B7-H3 (CD276) as a candidate therapeutic target in medullary thyroid cancer.

Journal: Endocrine-related cancer

Published: May 06, 2026

CXCR4-Targeted Molecular Imaging in Hematology and Oncology.

CXCR4-Targeted Molecular Imaging in Hematology and Oncology.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 22, 2026

Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real-World Case Series.

Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real-World Case Series.

Journal: EJHaem

Published: January 06, 2026

Real-world evidence from a tertiary academic center: clinical characteristics, microbiology and outcomes of oncology patients with febrile neutropenia presenting to the emergency department.

Real-world evidence from a tertiary academic center: clinical characteristics, microbiology and outcomes of oncology patients with febrile neutropenia presenting to the emergency department.

Journal: BMC infectious diseases

Published: December 26, 2025

Long-term complete remission following treatment with polatuzumab vedotin, rituximab, and bendamustine in a patient with mantle cell lymphoma relapsing after CAR-T cell therapy: a case report.

Long-term complete remission following treatment with polatuzumab vedotin, rituximab, and bendamustine in a patient with mantle cell lymphoma relapsing after CAR-T cell therapy: a case report.

Journal: Therapeutic advances in medical oncology

Published: December 23, 2025

Patient characteristics and prognostic factors in advanced treatment lines in metastatic neuroendocrine tumors.

Patient characteristics and prognostic factors in advanced treatment lines in metastatic neuroendocrine tumors.

Journal: Journal of endocrinological investigation

Published: December 01, 2025

Field-testing the MALT-IPI in a single-center real-world cohort of patients with extranodal marginal zone lymphoma.

Field-testing the MALT-IPI in a single-center real-world cohort of patients with extranodal marginal zone lymphoma.

Journal: Blood advances

Published: November 13, 2025

Field-testing the MALT-IPI in a single center real-world cohort of patients with extranodal marginal zone lymphoma.

Field-testing the MALT-IPI in a single center real-world cohort of patients with extranodal marginal zone lymphoma.

Journal: Blood advances

Published: November 13, 2025

Oligometastatic neuroendocrine tumors: characteristics and prognosis.

Oligometastatic neuroendocrine tumors: characteristics and prognosis.

Journal: British journal of cancer

Published: November 03, 2025

Histological response dynamics in gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue after Helicobacter pylori eradication: a single-center longitudinal analysis.

Histological response dynamics in gastric extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue after Helicobacter pylori eradication: a single-center longitudinal analysis.

Journal: Haematologica

Published: October 14, 2025

Austrian Real-world Experience With Standard of Care Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle-Cell Lymphoma.

Austrian Real-world Experience With Standard of Care Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle-Cell Lymphoma.

Journal: Transplantation and cellular therapy

Published: August 26, 2025

Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whipplei.

Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whipplei.

Journal: Haematologica

Published: August 07, 2025

Showing 1-12 of 209

Last Updated: 09/26/2026